E-drug: Table of contents of Prescrire International - June 1999
----------------------------------------------------------
Table of contents of Prescrire International, June 99 - Volume 8 �
Nr. 41
Prescrire International is the English language edition of La revue
Prescrire. It consists of a selection of articles of international interest
from the monthly French-language journal La revue Prescrire. Prescrire
International contains evaluations of new drugs and new indications,
information on adverse effects, and assessments of therapeutic
interventions.
EDITORIAL
A farewell to sales reps
NEW PRODUCTS
Cysteamine (new preparation)
A real advance in the treatment of cystinosis
Bambuterol (new preparation)
No proven superiority over oral terbutaline or inhaled salmeterol
Hydroxychloroquine in light eruption (new indication)
Possibly helpful, few adverse effects as short courses
Gemcitabine and cancer of the pancreas (new preparation)
Slight advantage possibly offset by adverse effects
Valaciclovir in herpes zoster ophthalmicus (new indication)
Lack of evidence for use in herpes zoster ophthalmicus
Enoxaparin and dalteparin in unstable angina (new indication)
Enoxaparin offers an advantage in combination with aspirin
Dalteparin: no better than unfractionated heparin
Lamotrigine for adults and children (new indication)
Of use in epilepsy in adults and in the Lennox-Gastaut syndrome
ADVERSE EFFECTS
Check for pregnancy before prescribing clomifene
Lipomatosis due to chronic steroid therapy
Lactic acidosis due to metformin
Cardiovascular disorders due to latanoprost eye drops?
REVIEWS
Sales representatives
A damning report by Prescrire reps monitoring network
Antihypertensive drugs
Diuretics and betablockers are the best assessed and the cheapest
Prescrire International is financed by subscription fees only. We cannot
provide free subscriptions. If you do not know the journal we can send you
a sample issue. Send us your name and address if you want to receive a
sample issue of Prescrire International. An annual subscription covers six
issues of Prescrire International plus an index to issues during the
previous five years and costs US$ 60 (FF 310) for individuals, US$38 (FF
200) for students, and US$ 360 (FF1860) for commercial institutions.
Prescrire International
Association Mieux Prescrire
BP 459
75527 Paris Cedex 11
France
Tel. 33 1 47 00 94 45
Fax 33 1 48 07 87 32
email : international@prescrire.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.